CURE Pharmaceutical to Acquire Sera Labs, a Leader in the CBD Industry with Proprietary Products and Multi-Channel Distribution Platform, in a $20 Million Transaction

Cure Pharmaceutical Holding Corp. GlobeNewswire July 28, 2020 MOU to acquire 100% of privately held Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of completing the acquisition. Sera Labs brings to CURE a high-margin, retail and direct-to-consumer business…

Details

July 28, 2020

GoldHaven Files for Listing on the OTCQB

Newsfile Corp., Newsfile•July 21, 2020 Vancouver, British Columbia–(Newsfile Corp. – July 21, 2020) –  GoldHaven Resources Corp. (formerly Altum Resources Corp.) (the “Company” or “GoldHaven”) (CSE: GOH) is pleased to report that they have applied for its common shares to be listed for trading on the OTCQB Venture Market, a United States trading platform operated…

Details

July 21, 2020

Energy Fuels Strengthens Balance Sheet by Eliminating Debt and Growing Uranium Inventories

LAKEWOOD, Colo., July 17, 2020 /CNW/ – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) (“Energy Fuels” or the “Company”), the largest uranium mining company in the United States, is pleased to announce the recent elimination of a portion of the Company’s debt, confirmation of 2020 uranium production guidance, and updates on the value of the Company’s significant uranium and vanadium…

Details

July 20, 2020

CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel

GlobeNewswire•July 15, 2020 Significantly higher serum concentration and absorption Showcases CUREform™ encapsulation and oral thin film technology OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film (OTF) showed improved bioavailability of cannabidiol in healthy subjects,…

Details

July 15, 2020

CURE Pharmaceutical Receives NSF’s cGMP Certification for Dietary Supplements

GlobeNewswire•July 8, 2020 OXNARD, Calif., July 08, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today announced that its 25,000 square foot manufacturing facility has earned NSF International, cGMP certification for the manufacture of dietary supplements. This certification is issued only after extensive material and facility analysis and gives…

Details

July 8, 2020

Altum Announces Name Change and Date of AGM

Newsfile Corp –June 30, 2020 Vancouver, British Columbia–(Newsfile Corp. – June 30, 2020) – Altum Resource Corp. (CSE: ALTM) (the “Company” or “Altum”) is pleased to announce that it has changed its corporate name from “Altum Resource Corp.” to “GoldHaven Resources Corp.”. The Company’s name change reflects the Company’s focus on acquiring, exploring and developing…

Details

July 1, 2020

Altum Reports Results of 16.55 g/t Au, 46.4% Cu and 144 g/t Ag from its 2020 Adam West Exploration Program

Newsfile Corp. NewsfileJune 29, 2020   Vancouver, British Columbia–(Newsfile Corp. – June 29, 2020) – Altum Resource Corp. (CSE: ALTM) (“Altum” or the “Company”) is pleased to report the results from the first phase of its 2020 exploration program on its Adam West property (the “Property”) on northern Vancouver Island. After the positive results from…

Details

June 29, 2020

CURE Pharmaceutical Appoints Chief Business Officer

GlobeNewswire•June 16, 2020 – Jonathan Berlent Appointed to Newly Created Role – OXNARD, Calif., June 16, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Jonathan Berlent, 51, to the newly created position of Chief Business Officer. Mr. Berlent will be responsible for corporate strategy, sourcing and executing…

Details

June 16, 2020